Updated Jul 16, 2026
TAHL CINDY has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $69K.

| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | FATE | FATE THERAPEUTICS INC | S — Open-market sale | 25.6K | $1.88 | $48K |
| 2026-05-07 | FATE | FATE THERAPEUTICS INC | M — Option exercise | 44.4K | $1.05 | $47K |
| 2026-05-07 | FATE | FATE THERAPEUTICS INC | M — Option exercise | 122.2K | $1.32 | $161K |
| 2026-01-16 | FATE | FATE THERAPEUTICS INC | A — Grant or award | 100.0K | $0.00 | |
| 2026-01-12 | FATE | FATE THERAPEUTICS INC | S — Open-market sale | 10.6K | $1.06 | $11K |
| 2025-08-04 | FATE | FATE THERAPEUTICS INC | S — Open-market sale | 9.0K | $1.06 | $10K |
TAHL CINDY is a corporate insider — currently tracked as Insider of FATE THERAPEUTICS INC (FATE). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($69K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live TAHL CINDY profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.